Researchers will determine if common heart medications are an effective adjunct therapy for dogs with hemangiosarcoma.

Researchers will identify potential treatment targets for B-cell chronic lymphocytic leukemia in dogs and ways to identify high-risk patients.

Researchers will develop an assay to measure canine thrombopoietin (TPO), a bone marrow growth factor, to improve the diagnosis and treatment of bleeding disorders in dogs with immune platelet defects.

Researchers will determine if multiple parvovirus strains or other viruses are contributing to the re-emergence of panleukopenia, a severe and often fatal gastrointestinal infection in cats.

Researchers will explore novel ways to diagnose and predict the likelihood of a cat to develop feline infectious peritonitis, a highly fatal viral disease with no known cure.

Researchers will identify genes responsible for the lack of immune defenses associated with feline herpesvirus, a major cause of upper respiratory infections in cats, with the aim of developing a more effective vaccine.

Researchers will determine if genetic mutations are directly linked to how well or how poorly a cat with heart disease responds to clopidogrel, a blood thinner used to prevent life-threatening blood clot complications.

Researchers will evaluate the effectiveness of omeprazole, a gastric acid suppressant commonly prescribed to treat gastrointestinal symptoms in cats with chronic kidney disease.

Researchers will determine if genetic mutations are directly linked to how well or how poorly a cat with heart disease responds to clopidogrel, a blood thinner used to prevent life-threatening blood clot complications.

Morris Animal Foundation is partnering with Smithsonian Global Health to fund a wildlife health training program.